{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:07:22Z","timestamp":1790352442302,"version":"4.1.0"},"reference-count":61,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["K08CA222620"],"award-info":[{"award-number":["K08CA222620"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Androgen prohormones such as dehydroepiandrosterone (DHEA) increase in early puberty, peak in the second and third decade, and thereafter decline, independent of menopausal status. Investigators have examined their potential beneficial effects in normal women and those with DHEA-deficient states.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Acquisition<\/jats:title>\n                  <jats:p>A review of the literature from 1985 to 2021 on the potential benefits and risks of androgen prohormones in women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Synthesis<\/jats:title>\n                  <jats:p>Studies have examined the potential benefit of DHEA therapy for anti-aging, sexual dysfunction, infertility, metabolic bone health, cognition, and wellbeing in hormone-deficient states such as primary adrenal insufficiency, hypopituitarism, and anorexia as well as administration to normal women across the lifespan.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Data support small benefits in quality of life and mood but not for anxiety or sexual function in women with primary or secondary adrenal insufficiency or anorexia. No consistent beneficial effects of DHEA administration have been observed for menopausal symptoms, sexual function, cognition, or overall wellbeing in normal women. Local administration of DHEA shows benefit in vulvovaginal atrophy. Use of DHEA to improve induction of ovulation response in women with diminished ovarian reserve is not recommended. Risks of high physiologic or pharmacologic use of DHEA include androgenic and estrogenic side effects which are of concern for long-term administration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Case<\/jats:title>\n                  <jats:p>A 49-year-old woman with Addison\u2019s disease who is on low dose estrogen with cyclic progesterone therapy for menopausal symptoms returns for follow-up. She is on a stable glucocorticoid replacement strategy of hydrocortisone 10 mg in the morning and 5 mg in the early afternoon and fludrocortisone 0.05 mg each morning. She has read on the internet that additional therapy with DHEA may help her overall quality of life and libido. She asks whether she should add this therapy to her regimen and at what dose.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgac130","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T14:41:38Z","timestamp":1646664098000},"page":"1679-1685","source":"Crossref","is-referenced-by-count":28,"title":["Should Dehydroepiandrosterone Be Administered to Women?"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7634-1093","authenticated-orcid":false,"given":"Margaret E","family":"Wierman","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA"},{"name":"Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3341-582X","authenticated-orcid":false,"given":"Katja","family":"Kiseljak-Vassiliades","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA"},{"name":"Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"2022051722320470600_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1995.tb17368.x","article-title":"An abbreviated account of some aspects of the biochemistry of DHEA, 1934-1995","volume":"774","author":"Lieberman","year":"1995","journal-title":"Ann N Y Acad Sci."},{"issue":"11","key":"2022051722320470600_CIT0002","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s40265-014-0259-8","article-title":"Dehydroepiandrosterone (DHEA): hypes and hopes","volume":"74","author":"Rutkowski","year":"2014","journal-title":"Drugs."},{"key":"2022051722320470600_CIT0003","first-page":"411","article-title":"An adrenal-secreted \u201candrogen\u201d: dehydroisoandrosterone sulfate. its metabolism and a tentative generalization on the metabolism of other steroid conjugates in man","volume":"21","author":"Baulieu","year":"1965","journal-title":"Recent Prog Horm Res."},{"key":"2022051722320470600_CIT0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/bs.vh.2018.01.023","article-title":"DHEA modulates immune function: a review of evidence","volume":"108","author":"Prall","year":"2018","journal-title":"Vitam Horm."},{"issue":"12","key":"2022051722320470600_CIT0005","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1002\/eji.200526128","article-title":"Dehydroepiandrosterone replacement in patients with Addison\u2019s disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells","volume":"35","author":"Coles","year":"2005","journal-title":"Eur J Immunol."},{"issue":"2","key":"2022051722320470600_CIT0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0300-595X(86)80021-4","article-title":"Adrenal and gonadal androgen secretion in normal females","volume":"15","author":"Longcope","year":"1986","journal-title":"Clin Endocrinol Metab"},{"issue":"Suppl 4","key":"2022051722320470600_CIT0007","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger","year":"2002","journal-title":"Fertil Steril."},{"issue":"3","key":"2022051722320470600_CIT0008","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI105344","article-title":"Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone","volume":"45","author":"Horton","year":"1966","journal-title":"J Clin Invest."},{"key":"2022051722320470600_CIT0009","first-page":"1051","article-title":"Dehydroepiandrosterone and androsterone levels in human plasma: effect of age and sex; day-to-day and diurnal variations","volume-title":"J Clin Endocrinol Metab.","author":"Migeon","year":"1957","edition":"2"},{"issue":"3","key":"2022051722320470600_CIT0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1210\/jcem-59-3-551","article-title":"Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood","volume":"59","author":"Orentreich","year":"1984","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022051722320470600_CIT0011","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41574-020-0336-x","article-title":"11-Oxygenated androgens in health and disease","volume":"16","author":"Turcu","year":"2020","journal-title":"Nat Rev Endocrinol."},{"key":"2022051722320470600_CIT0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.08.016","article-title":"Intracrine androgen biosynthesis, metabolism and action revisited","volume":"465","author":"Schiffer","year":"2018","journal-title":"Mol Cell Endocrinol."},{"issue":"4","key":"2022051722320470600_CIT0013","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/jaoac\/83.4.847","article-title":"Liquid chromatographic determination of dehydroepiandrosterone (DHEA) in dietary supplement products","volume":"83","author":"Thompson","year":"2000","journal-title":"J AOAC Int."},{"issue":"1","key":"2022051722320470600_CIT0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/jcem-66-1-57","article-title":"Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men","volume":"66","author":"Nestler","year":"1988","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2022051722320470600_CIT0015","first-page":"3208","article-title":"Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects","volume":"85","author":"Legrain","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022051722320470600_CIT0016","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/jcem-71-3-696","article-title":"The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women","volume":"71","author":"Mortola","year":"1990","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2022051722320470600_CIT0017","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1073\/pnas.97.8.4279","article-title":"Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue","volume":"97","author":"Baulieu","year":"2000","journal-title":"Proc Natl Acad Sci USA."},{"issue":"6","key":"2022051722320470600_CIT0018","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archinte.163.6.720","volume":"163","author":"Percheron","year":"2003","journal-title":"Arch Intern Med."},{"issue":"16","key":"2022051722320470600_CIT0019","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa054629","article-title":"DHEA in elderly women and DHEA or testosterone in elderly men","volume":"355","author":"Nair","year":"2006","journal-title":"N Engl J Med."},{"issue":"6","key":"2022051722320470600_CIT0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4530(98)00032-8","article-title":"Opposing effects of DHEA replacement in elderly subjects on declarative memory and attention after exposure to a laboratory stressor","volume":"23","author":"Wolf","year":"1998","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"2022051722320470600_CIT0021","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00198-007-0520-z","article-title":"Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial","volume":"19","author":"von Muhlen","year":"2008","journal-title":"Osteoporos Int."},{"issue":"1","key":"2022051722320470600_CIT0022","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3758\/BF03196476","article-title":"The effect of dehydroepiandrosterone (DHEA) on recognition memory decision processes and discrimination in postmenopausal women","volume":"10","author":"Hirshman","year":"2003","journal-title":"Psychon Bull Rev."},{"issue":"4","key":"2022051722320470600_CIT0023","first-page":"CD006221","article-title":"Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people","volume":"2006","author":"Grimley Evans","year":"6221","journal-title":"Cochrane Database Syst Rev."},{"issue":"11","key":"2022051722320470600_CIT0024","first-page":"3896","article-title":"The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life","volume":"84","author":"Barnhart","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"2022051722320470600_CIT0025","first-page":"CD011066","article-title":"Dehydroepiandrosterone for women in the peri- or postmenopausal phase","volume":"1","author":"Scheffers","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"2022051722320470600_CIT0026","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/jc.2009-0032","article-title":"The approach to the adult with newly diagnosed adrenal insufficiency","volume":"94","author":"Arlt","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"14","key":"2022051722320470600_CIT0027","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM199909303411401","article-title":"Dehydroepiandrosterone replacement in women with adrenal insufficiency","volume":"341","author":"Arlt","year":"1999","journal-title":"N Engl J Med."},{"issue":"12","key":"2022051722320470600_CIT0028","first-page":"4650","article-title":"Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison\u2019s disease in a randomized, double blind trial","volume":"85","author":"Hunt","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022051722320470600_CIT0029","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1210\/jc.2002-020769","article-title":"Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial","volume":"88","author":"Lovas","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022051722320470600_CIT0030","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2007-1134","article-title":"Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial","volume":"93","author":"Gurnell","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022051722320470600_CIT0031","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2008-1982","article-title":"Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial","volume":"94","author":"Binder","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022051722320470600_CIT0032","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1210\/jcem.87.5.8494","article-title":"Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial","volume":"87","author":"Johannsson","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022051722320470600_CIT0033","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1210\/jc.2004-1802","article-title":"Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial","volume":"90","author":"van Thiel","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2022051722320470600_CIT0034","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1210\/jc.2009-0672","article-title":"A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency","volume":"94","author":"Alkatib","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2022051722320470600_CIT0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S2213-8587(13)70180-3","article-title":"Endocrine consequences of anorexia nervosa","volume":"2","author":"Misra","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11","key":"2022051722320470600_CIT0036","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1210\/jc.2002-020545","article-title":"Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial","volume":"87","author":"Gordon","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022051722320470600_CIT0037","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1359\/jbmr.1999.14.1.136","article-title":"Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa","volume":"14","author":"Gordon","year":"1999","journal-title":"J Bone Miner Res."},{"issue":"10","key":"2022051722320470600_CIT0038","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1210\/jc.2014-2261","article-title":"Clinical review: the benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis","volume":"99","author":"Elraiyah","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2022051722320470600_CIT0039","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1210\/jc.2014-2260","article-title":"Androgen therapy in women: a reappraisal: an endocrine society clinical practice guideline","volume":"99","author":"Wierman","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2022051722320470600_CIT0040","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1210\/jc.2019-01603","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"104","author":"Davis","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2022051722320470600_CIT0041","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1210\/jc.2006-1121","article-title":"Androgen therapy in women: an endocrine society clinical practice guideline","volume":"91","author":"Wierman","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022051722320470600_CIT0042","doi-asserted-by":"crossref","first-page":"hoy021","DOI":"10.1093\/hropen\/hoy021","article-title":"Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility","volume":"2019","author":"Costello","year":"2019","journal-title":"Hum Reprod Open"},{"issue":"1","key":"2022051722320470600_CIT0043","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41398-021-01249-2","article-title":"Plasma androgens and the presence and course of depression in a large cohort of women","volume":"11","author":"de Wit","year":"2021","journal-title":"Transl Psychiatry."},{"issue":"9","key":"2022051722320470600_CIT0044","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2174\/1871527317666180817153914","article-title":"Dehydroepiandrosterone (DHEA) for depression: a systematic review and meta-analysis","volume":"17","author":"Peixoto","year":"2018","journal-title":"CNS Neurol Disord Drug Targets."},{"issue":"2","key":"2022051722320470600_CIT0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/cen.13901","article-title":"Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials","volume":"90","author":"Jankowski","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2022051722320470600_CIT0046","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1210\/jc.2007-2614","article-title":"Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens","volume":"93","author":"Jankowski","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022051722320470600_CIT0047","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1210\/jc.2010-2888","article-title":"Clinical review: DHEA replacement for postmenopausal women","volume":"96","author":"Davis","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022051722320470600_CIT0048","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2265.1998.00507.x","article-title":"The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women","volume":"49","author":"Morales","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022051722320470600_CIT0049","first-page":"e1","article-title":"Effects of dehydroepiandrosterone (DHEA) supplementation on cortisol, leptin, adiponectin, and liver enzyme levels: a systematic review and meta-analysis of randomised clinical trials","volume":"2021","author":"Chen","year":"4698","journal-title":"Int J Clin Pract."},{"key":"2022051722320470600_CIT0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.vh.2018.02.003","article-title":"Mechanisms of action of dehydroepiandrosterone","volume":"108","author":"Clark","year":"2018","journal-title":"Vitam Horm."},{"issue":"18","key":"2022051722320470600_CIT0051","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1001\/jama.292.18.2243","article-title":"Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial","volume":"292","author":"Villareal","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"2022051722320470600_CIT0052","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/13697137.2014.946279","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and The North American Menopause Society","volume":"17","author":"Portman","year":"2014","journal-title":"Climacteric"},{"key":"2022051722320470600_CIT0053","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jsbmb.2013.08.002","article-title":"Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens","volume":"138","author":"Labrie","year":"2013","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"11","key":"2022051722320470600_CIT0054","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/GME.0000000000000910","article-title":"Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause","volume":"24","author":"Labrie","year":"2017","journal-title":"Menopause"},{"key":"2022051722320470600_CIT0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2017.03.014","article-title":"Comparison of intravaginal 6.5mg (0.50%) prasterone, 0.3mg conjugated estrogens and 10\u00b5g estradiol on symptoms of vulvovaginal atrophy","volume":"174","author":"Archer","year":"2017","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"6","key":"2022051722320470600_CIT0056","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/GME.0000000000001121","article-title":"Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from the North American Menopause Society and the International Society for the Study of Women\u2019s Sexual Health","volume":"25","author":"Faubion","year":"2018","journal-title":"Menopause"},{"issue":"9","key":"2022051722320470600_CIT0057","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1477-7827-9-67","article-title":"Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)","volume":"9","author":"Gleicher","year":"2011","journal-title":"Reprod Biol Endocrinol."},{"issue":"1","key":"2022051722320470600_CIT0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jgyn.2016.01.002","article-title":"The effect of dehydroepiandrosterone (DHEA) supplementation on women with diminished ovarian reserve (DOR) in IVF cycle: Evidence from a meta-analysis","volume":"46","author":"Qin","year":"2017","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"4","key":"2022051722320470600_CIT0059","first-page":"369","article-title":"DHEA use to improve likelihood of IVF\/ICSI success in patients with diminished ovarian reserve: a systematic review and meta-analysis","volume":"22","author":"Schwarze","year":"2018","journal-title":"JBRA Assist Reprod"},{"issue":"11-12","key":"2022051722320470600_CIT0060","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/dta.2519","article-title":"Metabolic and isotopic signature of short-term DHEA administration in women: comparison with findings in men","volume":"10","author":"Buisson","year":"2018","journal-title":"Drug Test Anal."},{"issue":"7","key":"2022051722320470600_CIT0061","doi-asserted-by":"crossref","first-page":"e040823","DOI":"10.1136\/bmjopen-2020-040823","article-title":"A prospective, phase II, single-centre, cross-sectional, randomised study investigating dehydroepiandrosterone supplementation and its profile in trauma: ADaPT","volume":"11","author":"Bentley","year":"2021","journal-title":"BMJ Open"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac130\/43048648\/dgac130.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/6\/1679\/43738762\/dgac130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/6\/1679\/43738762\/dgac130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T22:33:53Z","timestamp":1652826833000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/6\/1679\/6543726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3,7]]},"published-print":{"date-parts":[[2022,5,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac130","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,3,7]]}}}